Menu Search
Equities

Establishment Labs Holdings Inc

ESTA:NAQ

Establishment Labs Holdings Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)46.25
  • Today's Change-1.87 / -3.89%
  • Shares traded1.48m
  • 1 Year change+84.15%
  • Beta1.1743
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Establishment Labs Holdings Inc's net income fell 4.38% from a loss of 75.21m to a larger loss of 78.50m despite relatively flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 77.91% to 88.15%.
Gross margin66.04%
Net profit margin-54.97%
Operating margin-40.52%
Return on assets-29.17%
Return on equity-166.58%
Return on investment-34.29%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Establishment Labs Holdings Inc fell by 26.32m. Cash Flow from Financing totalled 86.23m or 52.21% of revenues. In addition the company used 88.51m for operations while cash used for investing totalled 24.55m.
Cash flow per share-2.91
Price/Cash flow per share--
Book value per share1.61
Tangible book value per share1.24
More ▼

Balance sheet in USDView more

Establishment Labs Holdings Inc has a Debt to Total Capital ratio of 81.14%, a lower figure than the previous year's 331.62%.
Current ratio4.44
Quick ratio2.91
Total debt/total equity4.30
Total debt/total capital0.8114
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.